Credit Suisse’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q1 | – | Sell |
-25,604
| Closed | -$17K | – | 4068 |
|
2015
Q4 | $17K | Sell |
25,604
-288
| -1% | -$191 | ﹤0.01% | 3946 |
|
2015
Q3 | $25K | Buy |
25,892
+291
| +1% | +$281 | ﹤0.01% | 3992 |
|
2015
Q2 | $31K | Sell |
25,601
-54,338
| -68% | -$65.8K | ﹤0.01% | 4190 |
|
2015
Q1 | $85K | Sell |
79,939
-15,900
| -17% | -$16.9K | ﹤0.01% | 3961 |
|
2014
Q4 | $104K | Sell |
95,839
-5,104
| -5% | -$5.54K | ﹤0.01% | 4045 |
|
2014
Q3 | $109K | Buy |
100,943
+22,913
| +29% | +$24.7K | ﹤0.01% | 3885 |
|
2014
Q2 | $81K | Buy |
78,030
+37,603
| +93% | +$39K | ﹤0.01% | 4137 |
|
2014
Q1 | $42K | Sell |
40,427
-6,740
| -14% | -$7K | ﹤0.01% | 4208 |
|
2013
Q4 | $55K | Buy |
47,167
+11,624
| +33% | +$13.6K | ﹤0.01% | 4068 |
|
2013
Q3 | $60K | Buy |
35,543
+19,536
| +122% | +$33K | ﹤0.01% | 3708 |
|
2013
Q2 | $32K | Buy |
+16,007
| New | +$32K | ﹤0.01% | 3724 |
|